From USFDA
Zydus Cadila has received the final approval from USFDA to market Amantadine Hydrochloride Capsules USP 100 mg. The drug which is used in the treatment of Parkinson's disease and select viral infection, will be produced at the group's formulations manufacturing facility at the Pharma SEZ Ahmedabad.Powered by Capital Market - Live News
